Hearing Status and Aural Rehabilitative Profile of 878 Patients With Sporadic Vestibular Schwannoma

Objectives/Hypothesis To examine the hearing status and aural rehabilitative profile in a national cohort of patients with sporadic vestibular schwannoma (VS). Study Design Cross‐sectional survey Methods A cross‐sectional survey of Acoustic Neuroma Association members diagnosed with sporadic VS was...

Full description

Saved in:
Bibliographic Details
Published in:The Laryngoscope 2021-06, Vol.131 (6), p.1378-1381
Main Authors: Macielak, Robert J., Marinelli, John P., Spear, Samuel A., Hahs‐Vaughn, Debbie L., Link, Michael J., Nye, Chad, Carlson, Matthew L.
Format: Article
Language:English
Subjects:
acoustic neuroma
Acoustic Neuroma Association
Adult
Aged
Brain cancer
Correction of Hearing Impairment - statistics & numerical data
Cross-Sectional Studies
Female
Hearing
Hearing aids
Hearing Aids - statistics & numerical data
Hearing Loss, Unilateral - physiopathology
Hearing Loss, Unilateral - rehabilitation
Humans
Laryngoscopy
Male
Middle Aged
Neuroma, Acoustic - physiopathology
Neuroma, Acoustic - rehabilitation
Polls & surveys
quality of life
rehabilitation
Treatment Outcome
United States
Vestibular schwannoma
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Objectives/Hypothesis To examine the hearing status and aural rehabilitative profile in a national cohort of patients with sporadic vestibular schwannoma (VS). Study Design Cross‐sectional survey Methods A cross‐sectional survey of Acoustic Neuroma Association members diagnosed with sporadic VS was performed from February 2017 through January 2019. Self‐reported results were used to determine the aural rehabilitative profile of respondents. Results Among survey respondents, 62.2% (546/878) were not using any hearing‐assistive device at time of survey. For the 37.8% (332/878) that were utilizing hearing‐assistive devices, 32.8% (109/332) reported using a behind‐the‐ear hearing aid, 23.8% (79/332) used a contralateral routing of signal (CROS) hearing aid, and 21.7% (72/332) used a bone conduction device. Notably, 41.9% (278/663) of patients who previously underwent tumor treatment reported utilizing a hearing rehabilitation device at some point during VS management compared to 27.0% (58/215) of those undergoing observation with serial imaging (P 
ISSN:0023-852X
1531-4995
DOI:10.1002/lary.29315